Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
International Journal of Clinical Oncology|January 14, 2016
Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in JapanArata Tsutsumida, Akira Takahashi, Kenjiro Namikawa, et al.Science Translational Medicine|December 4, 2024
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironmentTomoyuki Minowa, Kenji Murata, Yuka Mizue, et al.The Journal of Dermatology|September 19, 2019
Japanese real-world study of sequential nivolumab and ipilimumab treament in melanomaArata Tsutsumida, Satoshi Fukushima, Kenji Yokota, et al.The Journal of Dermatology|August 23, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/LymphomaKentaro Yonekura, Ikko Muto, Motoi Takenaka, et al.Journal of Clinical Immunology|November 6, 2022
Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial DiseasesRintaro Ono, Miyuki Tsumura, Saho Shima, et al.Journal of Dermatological Science|April 12, 2023
Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter studyTakashi Inozume, Kenjiro Namikawa, Hiroshi Kato, et al.The Journal of Dermatology|September 22, 2011
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanomaHisashi Uhara, Naoya Yamazaki, Minoru Takata, et al.Experimental Dermatology|January 8, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: ProtocolTaku Fujimura, Koji Yoshino, Hiroshi Kato, et al.International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.Cancer Medicine|August 16, 2023
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study)Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, et al.Pageof 13